UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662

Clinical pharmacology and therapeutics, 2014-07, Vol.96 (1), p.81-89

2014

Volltextzugriff (PDF)

Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography–triple quadrupole mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2008-05, Vol.867 (2), p.205-212

2008

Volltextzugriff (PDF)

Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel

Annals of oncology, 2014-10, Vol.25 (10), p.2059-2065

2014

Volltextzugriff (PDF)

Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine

Cancer chemotherapy and pharmacology, 2012, Vol.69 (1), p.25-33

2012

Volltextzugriff (PDF)

Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction

Cancer chemotherapy and pharmacology, 2014, Vol.73 (1), p.113-124

2014

Volltextzugriff (PDF)

Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography–tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2006-06, Vol.837 (1), p.49-58

2006

Volltextzugriff (PDF)

Pharmacokinetics and Clinical Efficacy of Phenobarbital in Asphyxiated Newborns Treated with Hypothermia: A Thermopharmacological Approach

Clinical pharmacokinetics, 2012-10, Vol.51 (10), p.671-679

2012

Volltextzugriff (PDF)

Identification and profiling of circulating metabolites of atazanavir, a HIV protease inhibitor

Drug metabolism and disposition, 2009-09, Vol.37 (9), p.1826-1840

2009

Volltextzugriff (PDF)

Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoring

Therapeutic drug monitoring, 2013-04, Vol.35 (2), p.168-176

2013

Volltextzugriff (PDF)

A validated assay for the quantitative analysis of vatalanib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-11, Vol.877 (29), p.3625-3630

2009

Volltextzugriff (PDF)

Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2009-02, Vol.49 (2), p.451-458

2009

Volltextzugriff (PDF)

Determinants of the elimination of methotrexate and 7‐hydroxy‐methotrexate following high‐dose infusional therapy to cancer patients

British journal of clinical pharmacology, 2006-07, Vol.62 (1), p.71-80

2006

Volltextzugriff (PDF)

Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry

Journal of pharmaceutical and biomedical analysis, 2009-02, Vol.49 (2), p.393-400

2009

Volltextzugriff (PDF)

Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2009-02, Vol.877 (5), p.575-580

2009

Volltextzugriff (PDF)

Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic–pharmacodynamic study

British journal of clinical pharmacology, 2007-11, Vol.64 (5), p.622-633

2007

Volltextzugriff (PDF)

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV‐1‐infected patients

British journal of clinical pharmacology, 2005-10, Vol.60 (4), p.378-389

2005

Volltextzugriff (PDF)

Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2004-05, Vol.804 (2), p.359-367

2004

Volltextzugriff (PDF)

PK PD Model of Indisulam and Capecitabine: Interaction Causes Excessive Myelosuppression

Clinical pharmacology and therapeutics, 2008-06, Vol.83 (6), p.829-839

2008

Volltextzugriff (PDF)

Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma

Cancer chemotherapy and pharmacology, 2005-05, Vol.55 (5), p.488-496

2005

Volltextzugriff (PDF)

Effects of cytochrome P450 3A (CYP3A) and the drug transporters P‐glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir

British journal of pharmacology, 2010-07, Vol.160 (5), p.1224-1233

2010

Volltextzugriff (PDF)

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin

Annals of oncology, 2002-03, Vol.13 (3), p.374-384

2002

Volltextzugriff (PDF)

Novel paclitaxel formulations for oral application : a phase I pharmacokinetic study in patients with solid tumours

Cancer chemotherapy and pharmacology, 2007-10, Vol.60 (5), p.635-642

2007

Volltextzugriff (PDF)

Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Journal of mass spectrometry., 2003-02, Vol.38 (2), p.157-166

2003

Volltextzugriff (PDF)

Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care

Journal of clinical pharmacy and therapeutics, 2004-04, Vol.29 (2), p.121-130

2004

Volltextzugriff (PDF)

Assessment of performance of manufacturing procedures in a unit for production of investigational anticancer agents, using a mixed effects analysis

Pharmaceutical research, 2007-03, Vol.24 (3), p.605-612

2007

Volltextzugriff (PDF)

1 – 25 von 118

Suche als RSS-Feed

Aktive Filter

ThemaPharmacology. Drug Treatments

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(113)
Mit Volltextzugriff
(111)

Publikationsform

Artikel
(118)

Sprache

Englisch
(118)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(118)
Medical Sciences
(118)
Humans
(112)
Life Sciences & Biomedicine
(111)
Science & Technology
(111)
Pharmacology & Pharmacy
(83)
Female
(67)
Male
(66)
Adult
(52)
Middle Aged
(47)
Antineoplastic Agents
(35)
General Pharmacology
(32)
Oncology
(27)
Aged
(25)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(24)
Analysis
(23)
Pharmacokinetics
(23)
Chemistry
(21)
Dose-Response Relationship, Drug
(21)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Association Analysis of Genetic Polymorphisms in Genes Related to Sunitinib Pharmacokinetics, Specifically Clearance of Sunitinib and SU12662

Quantification of protease inhibitors and non-nucleoside reverse transcriptase inhibitors in dried blood spots by liquid chromatography–triple quadrupole mass spectrometry

Optimizing anticancer drug treatment in pregnant cancer patients: pharmacokinetic analysis of gestation-induced changes for doxorubicin, epirubicin, docetaxel and paclitaxel

Gene polymorphisms, pharmacokinetics, and hematological toxicity in advanced non-small-cell lung cancer patients receiving cisplatin/gemcitabine

Safety and pharmacology of gemcitabine and capecitabine in patients with advanced pancreatico-biliary cancer and hepatic dysfunction

Development and validation of a quantitative assay for the measurement of two HIV-fusion inhibitors, enfuvirtide and tifuvirtide, and one metabolite of enfuvirtide (M-20) in human plasma by liquid chromatography–tandem mass spectrometry

Pharmacokinetics and Clinical Efficacy of Phenobarbital in Asphyxiated Newborns Treated with Hypothermia: A Thermopharmacological Approach

Identification and profiling of circulating metabolites of atazanavir, a HIV protease inhibitor

Quantification of sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry: validation and application in routine therapeutic drug monitoring

A validated assay for the quantitative analysis of vatalanib in human EDTA plasma by liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Quantification of the HIV-integrase inhibitor raltegravir and detection of its main metabolite in human plasma, dried blood spots and peripheral blood mononuclear cell lysate by means of high-performance liquid chromatography tandem mass spectrometry

Determinants of the elimination of methotrexate and 7‐hydroxy‐methotrexate following high‐dose infusional therapy to cancer patients

Quantification of etravirine (TMC125) in plasma, dried blood spots and peripheral blood mononuclear cell lysate by liquid chromatography tandem mass spectrometry

Quantification of HIV protease inhibitors and non-nucleoside reverse transcriptase inhibitors in peripheral blood mononuclear cell lysate using liquid chromatography coupled with tandem mass spectrometry

Safety and pharmacology of paclitaxel in patients with impaired liver function: a population pharmacokinetic–pharmacodynamic study

Population pharmacokinetics of lopinavir in combination with ritonavir in HIV‐1‐infected patients

Simultaneous quantification of the new HIV protease inhibitors atazanavir and tipranavir in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

PK PD Model of Indisulam and Capecitabine: Interaction Causes Excessive Myelosuppression

Pharmacokinetics of low-dose doxorubicin and metabolites in patients with AIDS-related Kaposi sarcoma

Effects of cytochrome P450 3A (CYP3A) and the drug transporters P‐glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir

Relationship between exposure and toxicity in high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin

Novel paclitaxel formulations for oral application : a phase I pharmacokinetic study in patients with solid tumours

Rapid quantification of HIV protease inhibitors in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry

Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care

Assessment of performance of manufacturing procedures in a unit for production of investigational anticancer agents, using a mixed effects analysis

Aktive Filter

Suchergebnisse filtern